Literature DB >> 12117708

Delayed diagnosis of US females with cystic fibrosis.

Hui-Chuan Lai1, Michael R Kosorok, Anita Laxova, Linda M Makholm, Philip M Farrell.   

Abstract

This study was conducted to examine a patient's age and condition at the time of diagnosis as one potential factor contributing to the "gender gap" in cystic fibrosis. The study population consisted of 11,275 US patients diagnosed during 1986-1998 and reported to the Cystic Fibrosis Foundation Registry in the same or the following calendar year. Parallel analyses were performed for Wisconsin patients identified prospectively during 1985-1994 to obtain more detailed information on their condition at diagnosis. Analyses of the registry data showed that females identified because of symptoms other than meconium ileus were diagnosed at significantly older ages (median, 12.7 months) than were males (median, 8.7 months) (p < 0.001). The delay in diagnosis for females was most evident among patients presenting with respiratory symptoms only (median, 40.7 vs. 22.3 months; p < 0.001). Analyses of Wisconsin patients demonstrated no significant gender differences in cough and wheezing experiences or in chest radiographic severity scores between males and females during their first 10 years of life, although a disproportionately high number of males were referred for diagnostic sweat testing. A delay in diagnosis of females with cystic fibrosis was discovered, suggesting either differential recognition of respiratory symptoms or a gender bias.

Entities:  

Mesh:

Year:  2002        PMID: 12117708     DOI: 10.1093/aje/kwf014

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

2.  Delayed cystic fibrosis presentation in children in the absence of newborn screening.

Authors:  A Jackson; L Foley; L Daly; P Fitzpatrick; M Harrington; S Zhou; C Kelleher
Journal:  Ir Med J       Date:  2010-04

3.  Sex and Gender Differences in Lung Disease.

Authors:  Patricia Silveyra; Nathalie Fuentes; Daniel Enrique Rodriguez Bauza
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Recovery of birth weight z score within 2 years of diagnosis is positively associated with pulmonary status at 6 years of age in children with cystic fibrosis.

Authors:  Huichuan J Lai; Suzanne M Shoff; Philip M Farrell
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

5.  Lung transplantation for cystic fibrosis.

Authors:  Frederick R Adler; Paul Aurora; David H Barker; Mark L Barr; Laura S Blackwell; Otto H Bosma; Samuel Brown; D R Cox; Judy L Jensen; Geoffrey Kurland; George D Nossent; Alexandra L Quittner; Walter M Robinson; Sandy L Romero; Helen Spencer; Stuart C Sweet; Wim van der Bij; J Vermeulen; Erik A M Verschuuren; Elianne J L E Vrijlandt; William Walsh; Marlyn S Woo; Theodore G Liou
Journal:  Proc Am Thorac Soc       Date:  2009-12

6.  Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

Authors:  Don B Sanders; Zhanhai Li; Anita Laxova; Michael J Rock; Hara Levy; Jannette Collins; Claude Ferec; Philip M Farrell
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 7.  The demographics of adverse outcomes in cystic fibrosis.

Authors:  Meghan E McGarry; Wadsworth A Williams; Susanna A McColley
Journal:  Pediatr Pulmonol       Date:  2019-11

8.  Cystic fibrosis mortality trends in Spain among infants and young children: 1981-2004.

Authors:  Enrique Ramalle-Gomara; Milagros Perucha; María-Angeles González; Carmen Quiñones; Jesús Andrés; Manuel Posada
Journal:  Eur J Epidemiol       Date:  2008-06-13       Impact factor: 8.082

9.  Is newborn screening for cystic fibrosis a basic human right?

Authors:  Philip M Farrell
Journal:  J Cyst Fibros       Date:  2008-02-11       Impact factor: 5.482

10.  Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R.

Authors:  Anne Schmidt; Kerstin Wenninger; Nadja Niemann; Ulrich Wahn; Doris Staab
Journal:  Health Qual Life Outcomes       Date:  2009-12-02       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.